Immunogenicity of biotherapeutics: a need for consensus on flexibility of approach

Curr Drug Saf. 2010 Oct;5(4):272-4. doi: 10.2174/157488610792245975.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antibody Formation
  • Biological Products / adverse effects*
  • Biological Products / immunology*
  • Humans
  • Practice Guidelines as Topic

Substances

  • Biological Products